- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT07661563
Advancing Scalable Alcohol Brief Interventions in the ED: A Trial of Conversational AI With Digital Reinforcements (MICA-ED)
A Randomized Trial of an AI Intervention to Help Individuals With Risky Alcohol Use Among Emergency Department Patients
The goal of this clinical trial is to learn if a novel digital strategy combining a generative AI counseling agent (MICA) and weekly SMS boosters works to reduce risky drinking among Emergency Department patients.
Studieoversikt
Status
Forhold
Intervensjon / Behandling
Studietype
Registrering (Antatt)
Fase
- Ikke aktuelt
Kontakter og plasseringer
Studiesteder
-
-
California
-
Palo Alto, California, Forente stater, 94304
- Rekruttering
- Stanford University Medical Center
-
Ta kontakt med:
- Brian Suffoletto, MD
- Telefonnummer: 412-901-6892
- E-post: suffbp@stanford.edu
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Beskrivelse
Inclusion Criteria:
- For men: AUDIT-C score 4+
- For women: AUDIT-C score 3+
- Owns a mobile phone
- Reads English language
Exclusion Criteria:
- For women: current or planned pregnancy in next 12 months
- Prisoner
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Forebygging
- Tildeling: Randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Dobbelt
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
|---|---|
|
Eksperimentell: MICA
MICA is a generative AI-powered counseling agent that delivers brief Motivational Interviewing (MI)-consistent sessions, following the validated MI process (engagement, focusing, evoking, planning, and closing). It uses personalized prompts to promote autonomy and evoke change talk, ending with a session summary and satisfaction check. Participants will complete a MICA session (~5-10 min) in the ED and at 3 months. |
MICA is an AI chatbot that uses a secure API with ChatGPT and prompted to follow MI principles to support individuals in exploring and resolving ambivalence about their alcohol use. MICA follows a predefined conversational framework and steps: introduction, engagement, focusing, evoking, planning, and closing-adapted from Miller & Rollnick's Motivational Interviewing: Helping People Change (3rd ed.). |
|
Eksperimentell: MICA+SMS
This condition includes the MICA ED session, a 3-month booster, and 12 weeks of weekly SMS messages supporting self-monitoring, goal-setting, and adaptive strategies. Messages are tailored based on reported alcohol use and goal commitment, offering encouragement, feedback, and harm-reduction messaging. |
MICA is an AI chatbot that uses a secure API with ChatGPT and prompted to follow MI principles to support individuals in exploring and resolving ambivalence about their alcohol use. MICA follows a predefined conversational framework and steps: introduction, engagement, focusing, evoking, planning, and closing-adapted from Miller & Rollnick's Motivational Interviewing: Helping People Change (3rd ed.). Weekly SMS check-ins designed to support goal-setting, self-monitoring, and adaptive self-regulation strategies. Beginning the Sunday after enrollment, participants will engage with an automated SMS program once weekly for 12 weeks. Prompts include reporting on the past week's alcohol use and whether they are willing to commit to a drinking limit goal for the upcoming week. Responses trigger tailored feedback. |
|
Ingen inngripen: Standard care
Standard ED care and as-needed referral to alcohol resources |
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Mean weekly alcohol consumption
Tidsramme: Baseline, 3-, 6-, and 12-month follow-ups
|
Participants report (1) the average number of standard alcohol drinks each day of the week. Estimated weekly alcohol consumption will be calculated as the sum of all those drinks over 7 days. |
Baseline, 3-, 6-, and 12-month follow-ups
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Number of heavy drinking days
Tidsramme: Baseline, 3-, 6-, and 12-month follow-ups
|
Asking participants: "Over the past 30 days, how many days did you have 4+ standard drinks (women) / 5+ standard drinks (men)?" |
Baseline, 3-, 6-, and 12-month follow-ups
|
|
Max number of drinks per drinking day
Tidsramme: Baseline, 3-, 6-, and 12-month follow-ups
|
Asking participants, "Over the past 30 days, what is the most drinks you had on any single day?" |
Baseline, 3-, 6-, and 12-month follow-ups
|
|
AUDIT score
Tidsramme: Baseline, 3-, 6, 12-months
|
Alcohol Use Disorders Identification Test (AUDIT) is a 10 question screen for AUD (0-40 Scale; higher numbers indicate higher risk for AUD). |
Baseline, 3-, 6, 12-months
|
Andre resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
SIP-2R
Tidsramme: Baseline, 3-, 6-, and 12-months
|
Short Inventory of Problems (SIP-2R) is a 15-item questionnaire used to measure the negative consequences and harm caused by drinking alcohol. Score 0 to 45 (higher scores indicate more frequent or severe problems) |
Baseline, 3-, 6-, and 12-months
|
Samarbeidspartnere og etterforskere
Sponsor
Samarbeidspartnere
Etterforskere
- Hovedetterforsker: Brian Suffoletto, MS MS, Stanford University
Publikasjoner og nyttige lenker
Generelle publikasjoner
- Suffoletto B, Prieksaitis C, Rose C, Kim D, Pillai N, Pitre V. Feasibility and Acceptability of a Large Language Model-Based Motivational Interviewing Agent in the Emergency Department. Ann Emerg Med. 2026 Jan;87(1):121-123. doi: 10.1016/j.annemergmed.2025.08.021. Epub 2025 Oct 2. No abstract available.
- Suffoletto B, Preiksaitis C, Kim D, Rose C, Pitre V, Pillai N, Mandal M. AI counseling agent for motivational interviewing: Conversational processes associated with change talk in emergency department patients. J Subst Use Addict Treat. 2026 Nov;190:210053. doi: 10.1016/j.josat.2026.210053. Epub 2026 Jun 12.
Studierekorddatoer
Studer hoveddatoer
Studiestart (Faktiske)
Primær fullføring (Antatt)
Studiet fullført (Antatt)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- 86953
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
IPD-planbeskrivelse
All survey data from baseline through 12-month followups will be uploaded to the data repository (the National Institute on Alcohol Abuse and Alcoholism Data Archive (NIAAADA). All counseling sessions and SMS data will be de-identified and kept in a separate repository.
IPD-delingstidsramme
Data will be available within 1 year of study completion and available indefinitely.
Tilgangskriterier for IPD-deling
Individuals with appropriate ethical approval and access to the NIAAADA or a DUA with the PI.
IPD-deling Støtteinformasjonstype
- STUDY_PROTOCOL
- SEVJE
- ANALYTIC_CODE
- CSR
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .